MERCER GLOBAL ADVISORS INC /ADV

Position in INCY — Incyte Corp

CIK 853758 DENVER, CO

Position in INCY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,778,195

-$169,280 QoQ

Shares Held

93,266

+3.0% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 33.84084232196084.ToString("F0")% Shared 0.ToString("F0")% None 66.15915767803916.ToString("F0")%

Healthcare · as of Mar 31, 2026

MERCER GLOBAL ADVISORS INC /ADV holds $216,661,656 across 109 Biotechnology names. INCY ranks #6 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	831,428	$69,981,294
2	ORKA	Oruka Therapeutics, Inc.	802,470	$39,361,153
3	REGN	Regeneron Pharmaceuticals, Inc.	20,053	$15,493,749
4	CAPR	Capricor Therapeutics, Inc.	402,999	$12,251,169
5	VRTX	Vertex Pharmaceuticals Inc / Ma	22,762	$10,164,143
6	INCY	Incyte Corp This page	93,266	$8,778,195
7	ORMP	Oramed Pharmaceuticals Inc.	1,910,540	$6,495,836
8	EXEL	Exelixis, Inc.	136,747	$5,865,078

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,778,195	93,266	+3.0%	Shares	Sole	2026-05-15
2025-12-31	$8,947,475	90,589	+10.5%	Shares	Sole	2026-02-18
2025-09-30	$6,950,518	81,954	+154.5%	Shares	Sole	2025-11-14
2025-06-30	$2,193,092	32,204	+64.8%	Shares	Sole	2025-08-14
2025-03-31	$1,183,328	19,543	+156.3%	Shares	Sole	2025-05-15
2024-12-31	$526,589	7,624	+131.4%	Shares	Sole	2025-02-14
2024-09-30	$217,799	3,295	-90.6%	Shares	Sole	2024-11-14
2021-06-30	$2,962,049	35,208	+0.0%	Shares	Sole	2021-08-10
2021-03-31	$2,860,297	35,195	+2.0%	Shares	Sole	2021-08-10
2020-12-31	$3,001,505	34,508	+1.1%	Shares	Sole	2021-02-12
2020-09-30	$3,062,018	34,121	-0.2%	Shares	Sole	2020-12-10
2020-06-30	$3,553,382	34,177	-0.3%	Shares	Sole	2020-08-10
2020-03-31	$2,509,372	34,267	—	Shares	Sole	2020-05-18
No filing history on record for this holder in this stock.